Decreton, BenoitKlaus, David Christopher2025-03-272024-09-302024-06-19http://hdl.handle.net/10362/181501This thesis examines the optimal market entry strategy for Sanofi's expansion into the African insulin market. Grounded in a theoretical framework that identifies factors influencing the choice of market entry mode, the study evaluates internal capabilities and external conditions. Key findings suggest significant opportunities for Sanofi due to a largely untapped market, strong internal capabilities, and a growing demand for insulin. Recommendations include pursuing a greenfield venture in Kenya to establish production facilities in Africa. With the support of the local government and international institutions, Sanofi can minimize operational risks, reduce capital expenditures, and, ultimately, improve insulin accessibility across Africa.engMarket entry modeInsulin accessAfricaHealthcareCEMS MIMmaster thesis203866614